Outside in: Unraveling the Role of Neuroinflammation in the Progression of Parkinson's Disease

Staging of brain pathology related to sporadic Parkinson’s disease

Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777 · see citing works

Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease

Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240 · see citing works

Neurotoxic reactive astrocytes are induced by activated microglia

Liddelow, S. A., Guttenplan, K. A., Clarke, L. E., Bennett, F. C., Bohlen, C. J., Schirmer, L., Bennett, M. L., Münch, A. E., Chung, W.-S., Peterson, T. C., et al. (2017) · Nature · doi:10.1038/nature21029 · Cited by 7,971 · see citing works

Parkinson's disease: clinical features and diagnosis

Jankovic, J. (2008) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.131045 · Cited by 5,720 · see citing works

Astrocytes: Biology and pathology

Sofroniew, M. V., & Vinters, H. V. (2010) · Acta Neuropathologica · doi:10.1007/s00401-009-0619-8 · Cited by 5,196 · see citing works

Host-gut microbiota metabolic interactions

Nicholson, J. K., Holmes, E., Kinross, J., Burcelin, R., Gibson, G., Jia, W., & Pettersson, S. (2012) · Science · doi:10.1126/science.1223813 · Cited by 4,760 · see citing works

Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour

Cryan, J. F., & Dinan, T. G. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3346 · Cited by 4,572 · see citing works

Microglia-mediated neurotoxicity: uncovering the molecular mechanisms

Block, M. L., Zecca, L., & Hong, J.-S. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2038 · Cited by 4,110 · see citing works

Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease

Sampson, T. R., Debelius, J. W., Thron, T., Janssen, S., Shastri, G. G., Ilhan, Z. E., Challis, C., Schretter, C. E., Rocha, S., Gradinaru, V., et al. (2016) · Cell · doi:10.1016/j.cell.2016.11.018 · Cited by 3,622 · see citing works

Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis

Yano, J. M., Yu, K., Donaldson, G. P., Shastri, G. G., Ann, P., Ma, L., Nagler, C. R., Ismagilov, R. F., Mazmanian, S. K., & Hsiao, E. Y. (2015) · Cell · doi:10.1016/j.cell.2015.02.047 · Cited by 3,614 · see citing works

Mechanisms underlying inflammation in neurodegeneration

Glass, C. K., Saijo, K., Winner, B., Marchetto, M. C., & Gage, F. H. (2010) · Cell · doi:10.1016/j.cell.2010.02.016 · Cited by 3,580 · see citing works

Host microbiota constantly control maturation and function of microglia in the CNS

Erny, D., Hrabě de Angelis, A. L., Jaitin, D., Wieghofer, P., Staszewski, O., David, E., Keren-Shaul, H., Mahlakoiv, T., Jakobshagen, K., Buch, T., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.4030 · Cited by 3,569 · see citing works

AGEING AND PARKINSON'S DISEASE: SUBSTANTIA NIGRA REGIONAL SELECTIVITY

FEARNLEY, J. M., & LEES, A. J. (1991) · Brain · doi:10.1093/brain/114.5.2283 · Cited by 3,529 · see citing works

Gut microbiota, metabolites and host immunity

Rooks, M. G., & Garrett, W. S. (2016) · Nature reviews. Immunology · doi:10.1038/nri.2016.42 · Cited by 3,409 · see citing works

Ecological and Evolutionary Forces Shaping Microbial Diversity in the Human Intestine

Ley, R. E., Peterson, D. A., & Gordon, J. I. (2006) · Cell · doi:10.1016/j.cell.2006.02.017 · Cited by 3,358 · see citing works

Normal gut microbiota modulates brain development and behavior

Heijtz, R. D., Wang, S., Anuar, F., Qian, Y., Björkholm, B., Samuelsson, A., Hibberd, M. L., Forssberg, H., & Pettersson, S. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1010529108 · Cited by 3,228 · see citing works

GDNF: a Glial Cell Line-Derived Neurotrophic Factor for Midbrain Dopaminergic Neurons

Lin, L.-F. H., Doherty, D. H., Lile, J. D., Bektesh, S. L., & Collins, F. (1993) · Science · doi:10.1126/science.8493557 · Cited by 3,206 · see citing works

Postnatal microbial colonization programs the hypothalamic–pituitary–adrenal system for stress response in mice

Sudo, N., Chida, Y., Aiba, Y., Sonoda, J., Oyama, N., Yu, X., Kubo, C., & Koga, Y. (2004) · The Journal of Physiology · doi:10.1113/jphysiol.2004.063388 · Cited by 2,735 · see citing works

Stages in the development of Parkinson’s disease-related pathology

Braak, H., Ghebremedhin, E., Rüb, U., Bratzke, H., & Del Tredici, K. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0956-9 · Cited by 2,689 · see citing works

Molecular dissection of reactive astrogliosis and glial scar formation

Sofroniew, M. V. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2009.08.002 · Cited by 2,594 · see citing works

Genomic analysis of reactive astrogliosis

Zamanian, J. L., Xu, L., Foo, L. C., Nouri, N., Zhou, L., Giffard, R. G., & Barres, B. A. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.6221-11.2012 · Cited by 2,404 · see citing works

Purification and Characterization of Progenitor and Mature Human Astrocytes Reveals Transcriptional and Functional Differences with Mouse

Zhang, Y., Sloan, S. A., Clarke, L. E., Caneda, C., Plaza, C. A., Blumenthal, P. D., Vogel, H., Steinberg, G. K., Edwards, M. S. B., Li, G., et al. (2016) · Neuron · doi:10.1016/j.neuron.2015.11.013 · Cited by 2,295 · see citing works

Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration

Qin, L., Wu, X., Block, M. L., Liu, Y., Breese, G. R., Hong, J., Knapp, D. J., & Crews, F. T. (2007) · Glia · doi:10.1002/glia.20467 · Cited by 2,144 · see citing works

Microglia and macrophages in brain homeostasis and disease

Li, Q., & Barres, B. A. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.125 · Cited by 1,999 · see citing works

How neuroinflammation contributes to neurodegeneration

Ransohoff, R. M. (2016) · Science · doi:10.1126/science.aag2590 · Cited by 1,967 · cited 1× · see citing works

The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner

Clarke, G., Grenham, S., Scully, P., Fitzgerald, P., Moloney, R. D., Shanahan, F., Dinan, T. G., & Cryan, J. F. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.77 · Cited by 1,893 · see citing works

The GDNF family: Signalling, biological functions and therapeutic value

Airaksinen, M. S., & Saarma, M. (2002) · Nature reviews. Neuroscience · doi:10.1038/nrn812 · Cited by 1,832 · see citing works

Vascular Endothelial Growth Factor (VEGF) and Its Receptor (VEGFR) Signaling in Angiogenesis: A Crucial Target for Anti- and Pro-Angiogenic Therapies

Shibuya, M. (2011) · Genes & Cancer · doi:10.1177/1947601911423031 · Cited by 1,778 · see citing works

The Intestinal Microbiota Affect Central Levels of Brain-Derived Neurotropic Factor and Behavior in Mice

Bercik, P., Denou, E., Collins, J., Jackson, W., Lu, J., Jury, J., Deng, Y., Blennerhassett, P., Macri, J., McCoy, K. D., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.04.052 · Cited by 1,748 · see citing works

Neuroinflammation and M2 Microglia: The Good, the Bad, and the Inflamed

Cherry, J. D., Olschowka, J. A., & O’Banion, M. K. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-98 · Cited by 1,748 · see citing works

Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen

Braak, H., R�b, U., Gai, W. P., & Del Tredici, K. (2003) · Journal of Neural Transmission · doi:10.1007/s00702-002-0808-2 · Cited by 1,683 · see citing works

Neuroinflammation: The Devil Is in the Details

DiSabato, D. J., Quan, N., & Godbout, J. P. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13607 · Cited by 1,640 · see citing works

The central nervous system and the gut microbiome

Sharon, G., Sampson, T. R., Geschwind, D. H., & Mazmanian, S. K. (2016) · Cell · doi:10.1016/j.cell.2016.10.027 · Cited by 1,513 · see citing works

Signals from the gut microbiota to distant organs in physiology and disease

Schroeder, B. O., & Bäckhed, F. (2016) · Nature Medicine · doi:10.1038/nm.4185 · Cited by 1,409 · see citing works

Reduced anxiety-like behavior and central neurochemical change in germ-free mice: Behavior in germ-free mice

Neufeld, K. M., Kang, N., Bienenstock, J., & Foster, J. A. (2011) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2010.01620.x · Cited by 1,392 · see citing works

Colonic bacterial composition in Parkinson's disease

Keshavarzian, A., Green, S. J., Engen, P. A., Voigt, R. M., Naqib, A., Forsyth, C. B., Mutlu, E., & Shannon, K. M. (2015) · Movement Disorders · doi:10.1002/mds.26307 · Cited by 1,281 · see citing works

Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine

Nicklas, W. J., Vyas, I. L., & Heikkila, R. E. (1985) · Life Sciences · doi:10.1016/0024-3205(85)90146-8 · Cited by 1,266 · see citing works

Aggregated α‐synuclein activates microglia: a process leading to disease progression in Parkinson's disease

Zhang, W., Wang, T., Pei, Z., Miller, D. S., Wu, X., Block, M. L., Wilson, B., Zhang, W., Zhou, Y., Hong, J.-S., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-2751com · Cited by 1,265 · see citing works

Gut Microbiota and Metabolic Endotoxemia in Young Obese Mexican Subjects

Radilla-Vázquez, R. B., Parra‐Rojas, I., Martínez-Hernández, N. E., Márquez‐Sandoval, F., Illades‐Aguiar, B., & Castro-Alarcón, N. (2016) · Obesity Facts · doi:10.1159/000442479 · Cited by 1,200 · see citing works

Consumption of fermented milk product with probiotic modulates brain activity

Tillisch, K., Labus, J., Kilpatrick, L., Jiang, Z., Stains, J., Ebrat, B., Guyonnet, D., Legrain–Raspaud, S., Trotin, B., Naliboff, B., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.02.043 · Cited by 1,192 · see citing works

Blockade of Microglial Activation Is Neuroprotective in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Mouse Model of Parkinson Disease

Wu, D. C., Jackson-Lewis, V., Vila, M., Tieu, K., Teismann, P., Vadseth, C., Choi, D.-K., Ischiropoulos, H., & Przedborski, S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01763.2002 · Cited by 1,183 · see citing works

Microglia development follows a stepwise program to regulate brain homeostasis

Matcovitch-Natan, O., Winter, D. R., Giladi, A., Vargas Aguilar, S., Spinrad, A., Sarrazin, S., Ben-Yehuda, H., David, E., Zelada González, F., Perrin, P., et al. (2016) · Science · doi:10.1126/science.aad8670 · Cited by 1,180 · see citing works

Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease

Brochard, V., Combadière, B., Prigent, A., Laouar, Y., Perrin, A., Beray-Berthat, V., Bonduelle, O., Alvarez-Fischer, D., Callebert, J., Launay, J.-M., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36470 · Cited by 1,172 · see citing works

Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls

Unger, M. M., Spiegel, J., Dillmann, K.-U., Grundmann, D., Philippeit, H., Bürmann, J., Faßbender, K., Schwiertz, A., & Schäfer, K.-H. (2016) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2016.08.019 · Cited by 1,159 · see citing works

Astrocyte-mediated control of cerebral blood flow

Takano, T., Tian, G.-F., Peng, W., Lou, N., Libionka, W., Han, X., & Nedergaard, M. (2005) · Nature Neuroscience · doi:10.1038/nn1623 · Cited by 1,137 · see citing works

Microglial priming in neurodegenerative disease

Perry, V. H., & Holmes, C. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.38 · Cited by 1,127 · see citing works

Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson’s disease

Yun, S. P., Kam, T.-I., Panicker, N., Kim, S., Oh, Y., Park, J.-S., Kwon, S.-H., Park, Y. J., Karuppagounder, S. S., Park, H., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0051-5 · Cited by 1,123 · see citing works

Selective neuronal vulnerability in Parkinson disease

Surmeier, D. J., Obeso, J. A., & Halliday, G. M. (2017) · Nature reviews. Neuroscience · doi:10.1038/nrn.2016.178 · Cited by 1,120 · see citing works

The Complement System: An Unexpected Role in Synaptic Pruning During Development and Disease

Stephan, A. H., Barres, B. A., & Stevens, B. (2012) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-061010-113810 · Cited by 1,113 · see citing works

Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo

Tomac, A., Lindqvist, E., Lin, L.-F. H., Ögren, S. O., Young, D., Hoffer, B. J., & Olson, L. (1995) · Nature · doi:10.1038/373335a0 · Cited by 1,079 · see citing works

Parkinson's disease: a dual‐hit hypothesis

Hawkes, C. H., Del Tredici, K., & Braak, H. (2007) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2007.00874.x · Cited by 1,021 · see citing works

Clinical progression in Parkinson disease and the neurobiology of axons

Cheng, H., Ulane, C. M., & Burke, R. E. (2010) · Annals of Neurology · doi:10.1002/ana.21995 · Cited by 1,012 · see citing works

Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats

Holmqvist, S., Chutna, O., Bousset, L., Aldrin-Kirk, P., Li, W., Björklund, T., Wang, Z.-Y., Roybon, L., Melki, R., & Li, J.-Y. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1343-6 · Cited by 925 · see citing works

Gabapentin Receptor α2δ-1 Is a Neuronal Thrombospondin Receptor Responsible for Excitatory CNS Synaptogenesis

Eroglu, Ç., Allen, N. J., Susman, M. W., O'Rourke, N. A., Park, C. Y., Özkan, E., Chakraborty, C., Mulinyawe, S. B., Annis, D. S., Huberman, A. D., et al. (2009) · Cell · doi:10.1016/j.cell.2009.09.025 · Cited by 893 · see citing works

A Nurr1/CoREST Pathway in Microglia and Astrocytes Protects Dopaminergic Neurons from Inflammation-Induced Death

Saijo, K., Winner, B., Carson, C. T., Collier, J. G., Boyer, L., Rosenfeld, M. G., Gage, F. H., & Glass, C. K. (2009) · Cell · doi:10.1016/j.cell.2009.01.038 · Cited by 859 · see citing works

Vagotomy and subsequent risk of <scp>P</scp> arkinson's disease

Svensson, E., Horváth‐Puhó, E., Thomsen, R. W., Djurhuus, J. C., Pedersen, L., Borghammer, P., & Sørensen, H. T. (2015) · Annals of Neurology · doi:10.1002/ana.24448 · Cited by 806 · see citing works

Review: microglia of the aged brain: primed to be activated and resistant to regulation

Norden, D. M., & Godbout, J. P. (2013) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2012.01306.x · Cited by 792 · see citing works

Meta‐analysis of early nonmotor features and risk factors for Parkinson disease

Noyce, A. J., Bestwick, J. P., Silveira‐Moriyama, L., Hawkes, C. H., Giovannoni, G., Lees, A. J., & Schrag, A. E. (2012) · Annals of Neurology · doi:10.1002/ana.23687 · Cited by 772 · see citing works

Olfactory dysfunction in Parkinson disease

Doty, R. L. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.80 · Cited by 737 · see citing works

Microglia: biology and pathology

Graeber, M., & Streit, W. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0622-0 · Cited by 729 · see citing works

Microbiome-wide association studies link dynamic microbial consortia to disease

Gilbert, J. A., Quinn, R. A., Debelius, J. W., Xu, Z. Z., Morton, J. T., Garg, N., Jansson, J. K., Dorrestein, P. C., & Knight, R. D. (2016) · Nature · doi:10.1038/nature18850 · Cited by 714 · see citing works

Toll‐like receptor 4 is required for α‐synuclein dependent activation of microglia and astroglia

Fellner, L., Irschick, R., Schanda, K., Reindl, M., Klimaschewski, L., Poewe, W., Wenning, G. K., & Stefanova, N. (2013) · Glia · doi:10.1002/glia.22437 · Cited by 697 · see citing works

Revisiting the Mechanisms of CNS Immune Privilege

Louveau, A., Harris, T. H., & Kipnis, J. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.08.006 · Cited by 682 · see citing works

Redefining the concept of reactive astrocytes as cells that remain within their unique domains upon reaction to injury

Wilhelmsson, U., Bushong, E. A., Price, D. L., Smarr, B. L., Phung, V., Terada, M., Ellisman, M. H., & Pekny, M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602841103 · Cited by 643 · cited 1× · see citing works

The Role of Astrocyte Dysfunction in Parkinson’s Disease Pathogenesis

Booth, H. D. E., Hirst, W. D., & Wade-Martins, R. (2017) · Trends in Neurosciences · doi:10.1016/j.tins.2017.04.001 · Cited by 633 · see citing works

Colonic inflammation in Parkinson's disease

Devos, D., Lebouvier, T., Lardeux, B., Biraud, M., Rouaud, T., Pouclet, H., Coron, E., Bruley des Varannes, S., Naveilhan, P., Nguyen, J.-M., et al. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.09.007 · Cited by 627 · see citing works

The synaptic pathology of α-synuclein aggregation in dementia with Lewy bodies, Parkinson’s disease and Parkinson’s disease dementia

Schulz-Schaeffer, W. J. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0711-0 · Cited by 627 · see citing works

What Genetics Tells us About the Causes and Mechanisms of Parkinson's Disease

Corti, O., Lesage, S., & Brice, A. (2011) · Physiological Reviews · doi:10.1152/physrev.00022.2010 · Cited by 610 · see citing works

Basic mechanisms of neurodegeneration: a critical update

Jellinger, K. A. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01010.x · Cited by 608 · see citing works

Activated macrophages are an adaptive element of the colonic epithelial progenitor niche necessary for regenerative responses to injury

Pull, S. L., Doherty, J. M., Mills, J. C., Gordon, J. I., & Stappenbeck, T. S. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405979102 · Cited by 605 · see citing works

The parkinson's complex: Parkinsonism is just the tip of the iceberg

Langston, J. W. (2006) · Annals of Neurology · doi:10.1002/ana.20834 · Cited by 585 · see citing works

Inflammatory Response in the CNS: Friend or Foe?

Sochocka, M., Diniz, B. S., & Leszek, J. (2017) · Molecular Neurobiology · doi:10.1007/s12035-016-0297-1 · Cited by 573 · see citing works

Microglial cell dysregulation in brain aging and neurodegeneration

von Bernhardi, R., Eugenín-von Bernhardi, L., & Eugenín, J. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00124 · Cited by 556 · see citing works

Parkin Protects against the Toxicity Associated with Mutant α-Synuclein

Petrucelli, L., O’Farrell, C., Lockhart, P. J., Baptista, M. J., Kehoe, K. J., Vink, L., Choi, P., Wolozin, B. L., Farrer, M. J., Hardy, J., et al. (2002) · Neuron · doi:10.1016/s0896-6273(02)01125-x · Cited by 552 · see citing works

Understanding the role of gut microbiome–host metabolic signal disruption in health and disease

Holmes, E., Li, J. V., Athanasiou, T., Ashrafian, H., & Nicholson, J. K. (2011) · Trends in Microbiology · doi:10.1016/j.tim.2011.05.006 · Cited by 541 · see citing works

Biology of vascular endothelial growth factors

Roy, H., Bhardwaj, S., & Ylä‐Herttuala, S. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.03.087 · Cited by 537 · see citing works

Intestinal dysbiosis and lowered serum lipopolysaccharide-binding protein in Parkinson's disease

Hasegawa, S., Goto, S., Tsuji, H., Okuno, T., Asahara, T., Nomoto, K., Shibata, A., Fujisawa, Y., Minato, T., Okamoto, A., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0142164 · Cited by 523 · see citing works

Specification and Morphogenesis of Astrocytes

Freeman, M. R. (2010) · Science · doi:10.1126/science.1190928 · Cited by 489 · see citing works

A Guide to Neurotoxic Animal Models of Parkinson's Disease

Tieu, K. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a009316 · Cited by 483 · see citing works

Local distribution of microglia in the normal adult human central nervous system differs by up to one order of magnitude

Mittelbronn, M., Dietz, K., Schluesener, H. J., & Meyermann, R. (2001) · Acta Neuropathologica · doi:10.1007/s004010000284 · Cited by 482 · see citing works

Rotenone destroys dopaminergic neurons and induces parkinsonian symptoms in rats

Alam, M., & Schmidt, W. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(02)00180-8 · Cited by 475 · see citing works

Ly6Chi Monocytes Provide a Link between Antibiotic-Induced Changes in Gut Microbiota and Adult Hippocampal Neurogenesis

Möhle, L., Mattei, D., Heimesaat, M. M., Bereswill, S., Fischer, A., Alutis, M., French, T., Hambardzumyan, D., Matzinger, P., Dunay, I. R., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.04.074 · Cited by 470 · see citing works

Is alpha-synuclein in the colon a biomarker for premotor Parkinson’s disease? Evidence from 3 cases

Shannon, K. M., Keshavarzian, A., Dodiya, H. B., Jakate, S., & Kordower, J. H. (2012) · Movement Disorders · doi:10.1002/mds.25020 · Cited by 464 · see citing works

A large kindred with autosomal dominant Parkinson's disease

Golbe, L., Iorio, G. D., Bonavita, V., Miller, D. C., & Duvoisin, R. (1990) · Annals of Neurology · doi:10.1002/ana.410270309 · Cited by 463 · see citing works

An Inflammation-Centric View of Neurological Disease: Beyond the Neuron

Skaper, S. D., Facci, L., Zusso, M., & Giusti, P. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00072 · Cited by 461 · see citing works

Glial cell line-derived neurotrophic factor reverses toxin-induced injury to midbrain dopaminergic neurons in vivo

Hoffer, B. J., Hoffman, A. F., Bowenkamp, K., Huettl, P. F., Hudson, J., Martin, D., Lin, L.-F. H., & Gerhardt, G. A. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90218-6 · Cited by 453 · see citing works

Novel neurotrophic factor CDNF protects and rescues midbrain dopamine neurons in vivo

Lindholm, P., Voutilainen, M. H., Laurén, J., Peränen, J., Leppänen, V., Andressoo, J., Lindahl, M., Janhunen, S. K., Kalkkinen, N., Timmusk, T., et al. (2007) · Nature · doi:10.1038/nature05957 · Cited by 444 · see citing works

The Nigrostriatal Dopaminergic System Assessed In Vivo by Positron Emission Tomography in Healthy Volunteer Subjects and Patients With Parkinson's Disease

Leenders, K. L., Salmon, É., Tyrrell, P. J., Perani, D., Brooks, D. J., Sager, H., Jones, T., MARSDEN, C. D., & Frackowiak, R. S. J. (1990) · Archives of Neurology · doi:10.1001/archneur.1990.00530120034007 · Cited by 375 · see citing works

Bacterial Neuroactive Compounds Produced by Psychobiotics

Wall, R., Cryan, J. F., Ross, R. P., Fitzgerald, G. F., Dinan, T. G., & Stanton, C. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-1-4939-0897-4_10 · Cited by 362 · see citing works

MANF: A New Mesencephalic, Astrocyte-Derived Neurotrophic Factor with Selectivity for Dopaminergic Neurons

Petrova, P. S., Raibekas, A. A., Pevsner, J., Vigo, N. T., Anafi, M., Moore, M. K., Peaire, A. E., Shridhar, V., Smith, D. I., Kelly, J., et al. (2003) · Journal of Molecular Neuroscience · doi:10.1385/jmn:20:2:173 · Cited by 353 · see citing works

The role of α-synuclein in Parkinson's disease: insights from animal models

Lad, E. M., Dass, B., Collier, T. J., Kordower, J. H., & Steece‐Collier, K. (2003) · Nature reviews. Neuroscience · doi:10.1038/nrn1199 · Cited by 349 · see citing works

Targeting Microglial Activation States as a Therapeutic Avenue in Parkinson’s Disease

Subramaniam, S., & Federoff, H. J. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00176 · Cited by 343 · see citing works

Astrocytic expression of Parkinson's disease-related A53T α-synuclein causes neurodegeneration in mice

Gu, X., Long, C.-X., Sun, L., Xie, C., Lin, X. Z., & Cai, H. (2010) · Molecular Brain · doi:10.1186/1756-6606-3-12 · Cited by 341 · see citing works

MHC-I expression renders catecholaminergic neurons susceptible to T-cell-mediated degeneration

Cebrián, C., Zucca, F. A., Mauri, P., Steinbeck, J. A., Studer, L., Scherzer, C. R., Kanter, E., Budhu, S., Mandelbaum, J., Vonsattel, J. P., et al. (2014) · Nature Communications · doi:10.1038/ncomms4633 · Cited by 338 · see citing works

Reactive Astrogliosis after Spinal Cord Injury—Beneficial and Detrimental Effects

Karimi-Abdolrezaee, S., & Billakanti, R. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8287-4 · Cited by 331 · see citing works

The Role of Innate and Adaptive Immunity in Parkinson's Disease

Kannarkat, G. T., Boss, J. M., & Tansey, M. G. (2013) · Journal of Parkinson’s Disease · doi:10.3233/jpd-130250 · Cited by 324 · see citing works

The immunoregulatory role of dopamine: An update

Sarkar, C., Basu, B., Chakroborty, D., Dasgupta, P., & Basu, S. (2009) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2009.10.015 · Cited by 323 · see citing works

Inflammation induces mitochondrial dysfunction and dopaminergic neurodegeneration in the nigrostriatal system

Hunter, R. L., Dragicevic, N., Seifert, K., Choi, D. Y., Liu, M., Kim, H., Cass, W. A., Sullivan, P. G., & Bing, G. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04327.x · Cited by 322 · see citing works

Lentiviral vector delivery of parkin prevents dopaminergic degeneration in an α-synuclein rat model of Parkinson's disease

Bianco, C. L., Schneider, B. L., Bauer, M., Sajadi, A., Brice, A., Iwatsubo, T., & Aebischer, P. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405313101 · Cited by 322 · see citing works

Altered brain-gut axis in autism: comorbidity or causative mechanisms

Mayer, E. A., Padua, D., & Tillisch, K. (2014) · BioEssays · doi:10.1002/bies.201400075 · Cited by 304 · see citing works

Rotenone induces oxidative stress and dopaminergic neuron damage in organotypic substantia nigra cultures

Testa, C. M., Sherer, T., & Greenamyre, J. T. (2005) · Molecular Brain Research · doi:10.1016/j.molbrainres.2004.11.007 · Cited by 296 · see citing works

Pathological correlates of gastrointestinal dysfunction in Parkinson's disease

Cersosimo, M. G., & Benarroch, E. E. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.10.014 · Cited by 284 · see citing works

Reactive Astrogliosis Causes the Development of Spontaneous Seizures

Robel, S., Buckingham, S. C., Boni, J. L., Campbell, S. L., Danbolt, N. C., Riedemann, T., Sutor, B., & Sontheimer, H. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.1574-14.2015 · Cited by 283 · see citing works

New roles for VEGF in nervous tissue?beyond blood vessels

Rosenstein, J. M. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.01.022 · Cited by 281 · see citing works

Energy Metabolism of the Brain, Including the Cooperation between Astrocytes and Neurons, Especially in the Context of Glycogen Metabolism

Falkowska, A., Gutowska, I., Goschorska, M., Nowacki, P., Chlubek, D., & Baranowska-Bosiacka, I. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161125939 · Cited by 277 · see citing works

Dynamic changes in pro- and anti-inflammatory cytokines in microglia after PPAR-γ agonist neuroprotective treatment in the MPTPp mouse model of progressive Parkinson's disease

Pisanu, A., Lecca, D., Mulas, G., Wardas, J., Simbula, G., Spiga, S., & Carta, A. R. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.08.011 · Cited by 268 · see citing works

The impact of gut microbiota on brain and behaviour

Dinan, T. G., & Cryan, J. F. (2015) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000221 · Cited by 267 · see citing works

Protection and regeneration of nigral dopaminergic neurons by neurturin or GDNF in a partial lesion model of Parkinson's disease after administration into the striatum or the lateral ventricle

Rosenblad, C., Kirik, D., Devaux, B., Moffat, B., PHILLIPS, H. S., & Björklund, A. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00566.x · Cited by 261 · see citing works

The olfactory bulb as the entry site for prion-like propagation in neurodegenerative diseases

Rey, N. L., Wesson, D. W., & Brundin, P. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.12.013 · Cited by 257 · see citing works

T cell-microglial dialogue in Parkinson's disease and amyotrophic lateral sclerosis: are we listening?

Appel, S. H., Beers, D. R., & Henkel, J. S. (2010) · Trends in Immunology · doi:10.1016/j.it.2009.09.003 · Cited by 256 · see citing works

Disease‐modifying strategies for Parkinson's disease

Kalia, L. V., Kalia, S. K., & Lang, A. E. (2015) · Movement Disorders · doi:10.1002/mds.26354 · Cited by 254 · see citing works

Pharmacological Inhibition of Necroptosis Protects from Dopaminergic Neuronal Cell Death in Parkinson’s Disease Models

Iannielli, A., Bido, S., Folladori, L., Segnali, A., Cancellieri, C., Maresca, A., Massimino, L., Rubio, A., Morabito, G., Caporali, L., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.01.089 · Cited by 239 · see citing works

Olfactory bulb α-synucleinopathy has high specificity and sensitivity for Lewy body disorders

Beach, T. G., White, C. L., Hladik, C. L., Sabbagh, M. N., Connor, D. J., Shill, H. A., Sue, L. I., Sasse, J., Bachalakuri, J., Henry-Watson, J., et al. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0450-7 · Cited by 237 · see citing works

Vascular, glial and neuronal effects of vascular endothelial growth factor in mesencephalic explant cultures

Silverman, W. F., Krum, J. M., Mani, N., & Rosenstein, J. M. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00540-5 · Cited by 235 · see citing works

Jmjd3 is essential for the epigenetic modulation of microglia phenotypes in the immune pathogenesis of Parkinson’s disease

Tang, Y., Li, T., Li, J., Yang, J., Liu, H., Zhang, X.-X., & Le, W. (2013) · Cell Death and Differentiation · doi:10.1038/cdd.2013.159 · Cited by 221 · see citing works

Neuroprotective effects of vascular endothelial growth factor (VEGF) upon dopaminergic neurons in a rat model of Parkinson's disease

Yasuhara, T., Shingo, T., Kobayashi, K., Takeuchi, A., Yano, A., Muraoka, K., Matsui, T., Miyoshi, Y., Hamada, H., & Date, I. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03254.x · Cited by 216 · see citing works

Astrocytes convert the parkinsonism inducing neurotoxin, MPTP, to its active metabolite, MPP+

Ransom, B. R., Kunis, D. M., Irwin, I., & Langston, J. W. (1987) · Neuroscience Letters · doi:10.1016/0304-3940(87)90543-x · Cited by 209 · see citing works

M1 and M2 immune activation in Parkinson’s Disease: Foe and ally?

Moehle, M. S., & West, A. B. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.11.018 · Cited by 198 · see citing works

The in vivo neuron‐to‐astrocyte lactate shuttle in human brain: evidence from modeling of measured lactate levels during visual stimulation

Mangia, S., Simpson, I. A., Vannucci, S. J., & Carruthers, A. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06003.x · Cited by 189 · see citing works

Astrocyte-derived GDNF is a potent inhibitor of microglial activation

Rocha, S. M., Cristóvão, A. C., Campos, F. L., Fonseca, C. P., & Baltazar, G. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.04.014 · Cited by 179 · see citing works

GDNF fails to exert neuroprotection in a rat -synuclein model of Parkinson's disease

Decressac, M., Ulusoy, A., Mattsson, B., Georgievska, B., Romero‐Ramos, M., Kirik, D., & Björklund, A. (2011) · Brain · doi:10.1093/brain/awr149 · Cited by 178 · see citing works

Microglial Phenotype and Adaptation

Eggen, B. J. L., Raj, D. D. A., Hanisch, U., & Boddeke, H. W. G. M. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-013-9490-4 · Cited by 176 · see citing works

Mucuna pruriens Protects against MPTP Intoxicated Neuroinflammation in Parkinson’s Disease through NF-κB/pAKT Signaling Pathways

Rai, S. N., Birla, H., Singh, S. S., Zahra, W., Patil, R. R., Jadhav, J. P., Gedda, M. R., & Singh, S. P. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00421 · Cited by 161 · see citing works

Alpha-Synuclein Proteins Promote Pro-Inflammatory Cascades in Microglia: Stronger Effects of the A53T Mutant

Hoenen, C., Gustin, A., Birck, C., Kirchmeyer, M., Beaume, N., Felten, P., Grandbarbe, L., Heuschling, P., & Heurtaux, T. (2016) · PLOS ONE · doi:10.1371/journal.pone.0162717 · Cited by 159 · see citing works

The acute inflammatory response to intranigral α-synuclein differs significantly from intranigral lipopolysaccharide and is exacerbated by peripheral inflammation

Couch, Y., Alvarez-Erviti, L., Sibson, N. R., Wood, M. J., & Anthony, D. C. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-166 · Cited by 155 · see citing works

Evidence of Inflammatory System Involvement in Parkinson’s Disease

Chao, Y., Wong, S. C., & Tan, E. K. (2014) · BioMed Research International · doi:10.1155/2014/308654 · Cited by 150 · see citing works

Gut Microbiota Dysbiosis as Risk and Premorbid Factors of IBD and IBS Along the Childhood–Adulthood Transition

Putignani, L., CHIERICO, F. D., Vernocchi, P., Cicala, M., Cucchiara, S., & Dallapiccola, B. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000602 · Cited by 150 · see citing works

Protective role of chrysin on 6-hydroxydopamine-induced neurodegeneration a mouse model of Parkinson's disease: Involvement of neuroinflammation and neurotrophins

Goes, A. T. R., Jessé, C. R., Antunes, M. S., Ladd, F. V. L., Ladd, A. A. B. L., Luchese, C., Paroul, N., & Boeira, S. P. (2017) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2017.10.019 · Cited by 143 · see citing works

α-Synuclein Expression Modulates Microglial Activation Phenotype

Austin, S. A., Floden, A. M., Murphy, E. J., & Combs, C. K. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.1799-06.2006 · Cited by 142 · see citing works

Flavonoid Chrysin prevents age-related cognitive decline via attenuation of oxidative stress and modulation of BDNF levels in aged mouse brain

Souza, L. C., Antunes, M. S., Filho, C. B., Fabbro, L. D., de Gomes, M. G., Goes, A. T. R., Donato, F., Prigol, M., Boeira, S. P., & Jessé, C. R. (2015) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2015.04.010 · Cited by 141 · see citing works

Vascular endothelial growth factor is upregulated by l-dopa in the parkinsonian brain: implications for the development of dyskinesia

Ohlin, K. E., Francardo, V., Lindgren, H. S., Sillivan, S. E., O’Sullivan, S. S., Luksik, A. S., Vassoler, F. M., Lees, A. J., Konradi, C. L., & Cenci, M. A. (2011) · Brain · doi:10.1093/brain/awr165 · Cited by 140 · see citing works

Trophic Factor Gene Therapy for Parkinson's Disease

Kordower, J. H., & Björklund, A. (2013) · Movement Disorders · doi:10.1002/mds.25344 · Cited by 129 · see citing works

Chrysin improves cognitive deficits and brain damage induced by chronic cerebral hypoperfusion in rats

He, X.-L., Wang, Y., Ming-gang, B., & Du, G. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.01.025 · Cited by 124 · see citing works

Metabolic tinkering by the gut microbiome

Selkrig, J., Wong, P., Zhang, X., & Pettersson, S. (2014) · Gut Microbes · doi:10.4161/gmic.28681 · Cited by 116 · see citing works

VEGF-B

Li, X., Lee, C., Tang, Z., Zhang, F., Arjunan, P., Li, Y., Hou, X., Kumar, A., & Dong, L. (2009) · Cell Adhesion & Migration · doi:10.4161/cam.3.4.9459 · Cited by 112 · see citing works

Protective Microglia and Their Regulation in Parkinson’s Disease

Le, W., Wu, J., & Tang, Y. (2016) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00089 · Cited by 112 · see citing works

How can rAAV ‐α‐synuclein and the fibril α‐synuclein models advance our understanding of Parkinson's disease?

Volpicelli‐Daley, L. A., Kirik, D., Stoyka, L. E., Standaert, D. G., & Harms, A. S. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13627 · Cited by 110 · see citing works

MPTP-Induced Neuroinflammation Increases the Expression of Pro-Inflammatory Cytokines and Their Receptors in Mouse Brain

Lofrumento, D. D., Saponaro, C., Cianciulli, A., Nuccio, F. D., Mitolo, V., Nicolardi, G., & Panaro, M. A. (2010) · NeuroImmunoModulation · doi:10.1159/000320027 · Cited by 109 · see citing works

Macrophage-mediated GDNF Delivery Protects Against Dopaminergic Neurodegeneration: A Therapeutic Strategy for Parkinson's Disease

Biju, K. C., Zhou, Q., Li, G., Imam, S. Z., Roberts, J. L., Morgan, W. W., Clark, R. A., & Li, S. (2010) · Molecular Therapy · doi:10.1038/mt.2010.107 · Cited by 106 · see citing works

Glial Innate Immunity Generated by Non-Aggregated Alpha-Synuclein in Mouse: Differences between Wild-type and Parkinson's Disease-Linked Mutants

Roodveldt, C., Labrador‐Garrido, A., González‐Rey, E., Fernández-Montesinos, R., Caro, M., Lachaud, C. C., Waudby, C. A., Delgado, M., Dobson, C. M., & Pozo, D. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013481 · Cited by 99 · see citing works

Does Our Gut Microbiome Predict Cardiovascular Risk?

Griffin, J. L., Wang, X., & Stanley, E. G. (2015) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.114.000219 · Cited by 92 · see citing works

Necrostatin-1 protection of dopaminergic neurons

Cheng, Y., Wu, J., Wang, J., Zhou, S.-K., Yang, L., Yin, J.-L., & Cao, J. (2015) · Neural Regeneration Research · doi:10.4103/1673-5374.160108 · Cited by 91 · see citing works

Immune Responses in Parkinson’s Disease: Interplay between Central and Peripheral Immune Systems

Su, X., & Federoff, H. J. (2014) · BioMed Research International · doi:10.1155/2014/275178 · Cited by 91 · see citing works

Genetic variants and animal models in SNCA and Parkinson disease

Deng, H., & Yuan, L. (2014) · Ageing Research Reviews · doi:10.1016/j.arr.2014.04.002 · Cited by 89 · see citing works

Lack of PINK1 alters glia innate immune responses and enhances inflammation-induced, nitric oxide-mediated neuron death

Sun, L., Shen, R., Agnihotri, S. K., Chen, Y., Huang, Z., & Büeler, H. (2018) · Scientific Reports · doi:10.1038/s41598-017-18786-w · Cited by 87 · see citing works

GDNF-secreting mesenchymal stem cells provide localized neuroprotection in an inflammation-driven rat model of Parkinson’s disease

Hoban, D. B., Howard, L., & Dowd, E. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.07.014 · Cited by 86 · see citing works

Therapeutic potential of the endoplasmic reticulum located and secreted CDNF/MANF family of neurotrophic factors in Parkinson's disease

Voutilainen, M. H., Arumäe, U., Airavaara, M., & Saarma, M. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.09.031 · Cited by 83 · see citing works

A ventral glomerular deficit in Parkinson’s disease revealed by whole olfactory bulb reconstruction

Zapiec, B., Dieriks, B. V., Tan, S., Faull, R. L. M., Mombaerts, P., & Curtis, M. A. (2017) · Brain · doi:10.1093/brain/awx208 · Cited by 83 · see citing works

DAMPs and neurodegeneration

Thundyil, J., & Lim, K. (2014) · Ageing Research Reviews · doi:10.1016/j.arr.2014.11.003 · Cited by 82 · see citing works

Comparison of the neuroprotective potential of Mucuna pruriens seed extract with estrogen in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced PD mice model

Yadav, S. K., Prakash, J., Chouhan, S., Westfall, S., Verma, M., Singh, T. D., & Singh, S. P. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2013.12.001 · Cited by 80 · see citing works

Kir6.1/K-ATP channel modulates microglia phenotypes: implication in Parkinson’s disease

Du, R., Sun, H., Hu, Z., Lu, M., Ding, J., & Hu, G. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0437-9 · Cited by 80 · see citing works

Invited Article: Functional imaging in Parkinson disease

Nandhagopal, R., McKeown, M. J., & Stoessl, A. J. (2008) · Neurology · doi:10.1212/01.wnl.0000310432.92489.90 · Cited by 77 · see citing works

Prospects of Neurotrophic Factors for Parkinson's Disease: Comparison of Protein and Gene Therapy

Domanskyi, A., Saarma, M., & Airavaara, M. (2015) · Human Gene Therapy · doi:10.1089/hum.2015.065 · Cited by 76 · see citing works

General Anesthetics Inhibit LPS-Induced IL-1β Expression in Glial Cells

Tanaka, T., Kai, S., Matsuyama, T., Adachi, T., Fukuda, K., & Hirota, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082930 · Cited by 73 · see citing works

Vascular endothelial growth factor B (VEGF-B) is up-regulated and exogenous VEGF-B is neuroprotective in a culture model of Parkinson's disease

Falk, T., Zhang, S., & Sherman, S. J. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-49 · Cited by 71 · see citing works

Transient transfection of human CDNF gene reduces the 6-hydroxydopamine-induced neuroinflammation in the rat substantia nigra

Nadella, R., Voutilainen, M. H., Saarma, M., González-Barrios, J. A., León‐Chávez, B. A., Jiménez, J. M. D., Jiménez, S. H. D., Escobedo, L., & Martínez‐Fong, D. (2014) · Journal of Neuroinflammation · doi:10.1186/s12974-014-0209-0 · Cited by 71 · see citing works

Mechanisms of Anti-inflammatory Property of Conserved Dopamine Neurotrophic Factor: Inhibition of JNK Signaling in Lipopolysaccharide-Induced Microglia

Zhao, H., Cheng, L., Liu, Y., Zhang, W., Maharjan, S., Cui, Z., Wang, X., Tang, D., & Nie, L. (2013) · Journal of Molecular Neuroscience · doi:10.1007/s12031-013-0120-7 · Cited by 70 · see citing works

Angiotensin type 1 receptor blockage reduces l-dopa-induced dyskinesia in the 6-OHDA model of Parkinson's disease. Involvement of vascular endothelial growth factor and interleukin-1β

Muñoz, A., Garrido‐Gil, P., Dominguez‐Meijide, A., & Labandeira-García, J. L. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.08.019 · Cited by 69 · see citing works

A not entirely benign procedure: progression of Parkinson’s disease

Tredici, K. D., & Braak, H. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0355-5 · Cited by 67 · see citing works

Neuroinflammation in Parkinson’s Disease Animal Models: A Cell Stress Response or a Step in Neurodegeneration?

Cebrián, C., Loike, J. D., & Sulzer, D. (2014) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2014_356 · Cited by 65 · see citing works

Brain delivery of microencapsulated GDNF induces functional and structural recovery in parkinsonian monkeys

Garbayo, E., Ansorena, E., Lana, H., Carmona‐Abellán, M., Marcilla, I., Lanciego, J. L., Luquín, M. R., & Blanco‐Prieto, M. J. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.09.015 · Cited by 65 · see citing works

Overexpression of conserved dopamine neurotrophic factor (CDNF) in astrocytes alleviates endoplasmic reticulum stress-induced cell damage and inflammatory cytokine secretion

Cheng, L., Zhao, H., Zhang, W., Liu, B., Liu, Y., Guo, Y., & Nie, L. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.04.029 · Cited by 64 · see citing works

Increased antiparkinson efficacy of the combined administration of VEGF- and GDNF-loaded nanospheres in a partial lesion model of Parkinson’s disease

Hernández, R. M., Herrán, E., Requejo, C., Ruíz-Ortega, J. Á., Aristieta, A., Igartúa, M., Bengoetxea, H., Ugedo, L., Pedraz, J. L., & Lafuente, J. V. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s61940 · Cited by 63 · see citing works

Microglia-Derived Cytokines/Chemokines Are Involved in the Enhancement of LPS-Induced Loss of Nigrostriatal Dopaminergic Neurons in DJ-1 Knockout Mice

Chien, C.-H., Lee, M., Liou, H., Liou, H., & Fu, W. (2016) · PLoS ONE · doi:10.1371/journal.pone.0151569 · Cited by 63 · see citing works

Cancer and the microbiome: potential applications as new tumor biomarker

Shahanavaj, K., Bazo, I. G., Castiglia, M., Bronte, G., Passiglia, F., Carreca, A. P., del Pozo, J. L., Russo, A. D., Peeters, M., & Rolfo, C. D. (2014) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.2015.992785 · Cited by 62 · see citing works

Vascular endothelial growth factor-B is neuroprotective in an in vivo rat model of Parkinson's disease

Falk, T., Yue, X., Zhang, S., McCourt, A. D., Yee, B., Gonzalez, R. T., & Sherman, S. J. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.03.088 · Cited by 59 · see citing works

Non-motor symptoms: Identification and management

Muzerengi, S., Contrafatto, D., & Chaudhuri, К. R. (2007) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(08)70048-8 · Cited by 58 · see citing works

Favorable effects of VEGF gene transfer on a rat model of Parkinson disease using adeno-associated viral vectors

Tian, Y., Tang, C., Wang, J., Feng, Y., Chen, X., Wang, L., Qiao, X., & Sun, S.-G. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.05.033 · Cited by 56 · see citing works

Alpha-Synuclein mRNA Is Not Increased in Sporadic PD and Alpha-Synuclein Accumulation Does Not Block GDNF Signaling in Parkinson's Disease and Disease Models

Su, X., Fischer, D. L., Li, X., Bankiewicz, K. S., Sortwell, C. E., & Federoff, H. J. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.04.018 · Cited by 56 · see citing works

Comparative study of the neurotrophic effects elicited by VEGF-B and GDNF in preclinical in vivo models of Parkinson’s disease

Yue, X., Hariri, D. J., Caballero, B., Zhang, S., Bartlett, M. J., Kaut, O., Mount, D. W., Wüllner, U., Sherman, S. J., & Falk, T. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.11.038 · Cited by 53 · see citing works

Therapeutic effects of paeonol on methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid-induced Parkinson's disease in mice

Shi, X., Chen, Y., Liu, H., & Qu, H. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5573 · Cited by 53 · see citing works

Neurotrophic factors hold promise for the future of Parkinson’s disease treatment: is there a light at the end of the tunnel?

Nasrolahi, A., Mahmoudi, J., Akbarzadeh, A., Karimipour, M., Sadigh‐Eteghad, S., Salehi, R., & Farhoudi, M. (2018) · Reviews in the Neurosciences · doi:10.1515/revneuro-2017-0040 · Cited by 52 · see citing works

The Solution Structure and Dynamics of Full-length Human Cerebral Dopamine Neurotrophic Factor and Its Neuroprotective Role against α-Synuclein Oligomers

Cristiane, L., Cabral, K. M. D. S., de Oliveira, G. A. P., Raymundo, D. P., de Freitas, J. A., Johanson, L., Romão, L. F., Palhano, F. L., Herrmann, T., Almeida, M. S., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.662254 · Cited by 49 · see citing works

GDNF revisited: A novel mammalian cell-derived variant form of GDNF increases dopamine turnover and improves brain biodistribution

Grondin, R., Littrell, O. M., Zhang, Z., Ai, Y., Huettl, P. F., Pomerleau, F., Quintero, J. E., Andersen, A. H., Stenslik, M. J., Bradley, L. H., et al. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.05.014 · Cited by 49 · see citing works

Transcriptome Analysis Reveals Neuroprotective aspects of Human Reactive Astrocytes induced by Interleukin 1β

Teh, D. B. L., Prasad, A., Jiang, W., Ariffin, M. Z., Khanna, S., Belorkar, A., Wong, L., Liu, X., & All, A. H. (2017) · Scientific Reports · doi:10.1038/s41598-017-13174-w · Cited by 47 · see citing works

Comparison of subacute and chronic scar tissues after complete spinal cord transection

Li, X., Yang, B., Xiao, Z., Zhao, Y., Han, S., Yin, Y., Chen, B., & Dai, J. (2018) · Experimental Neurology · doi:10.1016/j.expneurol.2018.05.008 · Cited by 45 · see citing works

Expression of Tgfβ1 and Inflammatory Markers in the 6-hydroxydopamine Mouse Model of Parkinson’s Disease

Haas, S. J.-P., Zhou, X., Machado, V., Wree, A., KRIEGLSTEIN, K. G., & Spittau, B. (2016) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00007 · Cited by 44 · see citing works

GDNF-expressing macrophages mitigate loss of dopamine neurons and improve Parkinsonian symptoms in MitoPark mice

Chen, C., Li, X., Ge, G., Liu, J., Biju, K. C., Laing, S. D., Qian, Y., Ballard, C., He, Z., Masliah, E., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-23795-4 · Cited by 44 · see citing works

A case of late onset sporadic Parkinson's disease with an A53T mutation in -synuclein

Michell, A. W. (2005) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2004.046425 · Cited by 41 · see citing works

Neurorestoration

Airavaara, M., Voutilainen, M. H., Wang, Y., & Hoffer, B. J. (2011) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(11)70045-1 · Cited by 40 · see citing works

The Enemy within: Innate Surveillance-Mediated Cell Death, the Common Mechanism of Neurodegenerative Disease

Richards, R. I., Robertson, S. A., O’Keefe, L. V., Fornarino, D. L., Scott, A., Lardelli, M. T., & Baune, B. T. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00193 · Cited by 37 · see citing works

Insights into the Mechanisms Involved in Protective Effects of VEGF-B in Dopaminergic Neurons

Caballero, B. R., Sherman, S. J., & Falk, T. (2017) · Parkinson s Disease · doi:10.1155/2017/4263795 · Cited by 37 · see citing works

Non-motor symptoms in genetically defined dystonia: Homogenous groups require systematic assessment

Peall, K. J., Kuiper, A., de Koning, T. J., & Tijssen, M. A. J. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.07.003 · Cited by 34 · see citing works

6‐hydroxydopamine‐induced Parkinson's disease‐like degeneration generates acute microgliosis and astrogliosis in the nigrostriatal system but no bioluminescence imaging‐detectable alteration in adult neurogenesis

Fricke, I. B., Viel, T., Worlitzer, M. M. A., Collmann, F. M., Vrachimis, A., Faust, A., Wachsmuth, L., Faber, C., Dollé, F., Kuhlmann, M. T., et al. (2016) · European Journal of Neuroscience · doi:10.1111/ejn.13232 · Cited by 33 · see citing works

Inflammatory Cells and Cytokines in the Olfactory Bulb of a Rat Model of Neuroinflammation; Insights into Neurodegeneration?

Doursout, M., Schurdell, M. S., Young, L. M., Osuagwu, U., Hook, D. M., Poindexter, B. J., Schiess, M. C., Bick, D. L. M., & Bick, R. J. (2013) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2012.0088 · Cited by 31 · see citing works

The management of gastrointestinal symptoms in Parkinson’s disease

Salat-Foix, D., & Suchowersky, O. (2012) · Expert Review of Neurotherapeutics · doi:10.1586/ern.11.192 · Cited by 30 · see citing works

Autonomic dysfunction in genetic forms of synucleinopathies

Chelban, V., Vichayanrat, E., Schottlaende, L., Iodice, V., & Houlden, H. (2018) · Movement Disorders · doi:10.1002/mds.27343 · Cited by 28 · see citing works

Combination of CDNF and Deep Brain Stimulation Decreases Neurological Deficits in Late-stage Model Parkinson’s Disease

Huotarinen, A., Penttinen, A., Bäck, S., Voutilainen, M. H., Julku, U. H., Piepponen, P. T., Männistö, P. T., Saarma, M., Tuominen, R. K., Laakso, A., et al. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.01.052 · Cited by 28 · see citing works

Predicting alpha-synuclein pathology by REM sleep behavior disorder diagnosis

Shprecher, D., Adler, C. H., Zhang, N., Hentz, J. G., Serrano, G. E., Dugger, B. N., Shill, H. A., Savica, R., Caviness, J. N., Sabbagh, M. N., et al. (2018) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2018.05.020 · Cited by 26 · see citing works

Intracerebral administration of ultrasound-induced dissolution of lipid-coated GDNF microbubbles provides neuroprotection in a rat model of Parkinson's disease

Wang, X., Cui, G., Yang, X., Zhang, Z., Shi, H., Zu, J., Hua, F., & Shen, X. (2014) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2014.02.006 · Cited by 25 · see citing works

Theoretical Approaches to Lentiviral Mediated Neurotrophin Delivery in Potential Treatments of Parkinson's Disease.

Qudrat, A., & Rajesh, N. U. (2016) · PubMed Central · Cited by 1 · see citing works

The blood-brain barrier in aging and neurodegeneration

Knox, E. G., Aburto, M. R., Clarke, G., Cryan, J. F., & O’Driscoll, C. M. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01511-z · Cited by 738 · see citing works

Impact of microbiota on central nervous system and neurological diseases: the gut-brain axis

Ma, Q., Xing, C., Long, W., Wang, H. Y., Liu, Q., & Wang, R. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1434-3 · Cited by 752 · see citing works

Vascular Inflammation and Oxidative Stress: Major Triggers for Cardiovascular Disease

Steven, S., Frenis, K., Oelze, M. W., Kalinovic, S., Kuntić, M., Jiménez, M. T. B., Vujačić-Mirski, K., Helmstädter, J., Kröller‐Schön, S., Münzel, T. F., et al. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/7092151 · Cited by 729 · see citing works

Glutamate-induced excitotoxicity in Parkinson's disease: The role of glial cells

Iovino, L., Tremblay, M., & Civiero, L. (2020) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2020.07.011 · Cited by 370 · see citing works

Glucagon-like peptide-1 (GLP-1) receptor agonists and neuroinflammation: Implications for neurodegenerative disease treatment

Kopp, K. O., Glotfelty, E. J., Li, Y., & Greig, N. H. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106550 · Cited by 298 · see citing works

Neurosteroids as regulators of neuroinflammation

Yılmaz, C., Karali, K., Fodelianaki, G., Gravanis, A., Chavakis, T., Charalampopoulos, I., & Alexaki, V. I. (2019) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2019.100788 · Cited by 245 · see citing works

Neuroinflammation and Parkinson’s Disease—From Neurodegeneration to Therapeutic Opportunities

Araújo, B., Caridade-Silva, R., Soares-Guedes, C., Martins‐Macedo, J., Gomes, E. D., Monteiro, S., & Teixeira, F. G. (2022) · Cells · doi:10.3390/cells11182908 · Cited by 198 · see citing works

Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology

Ribeiro, D. E., Oliveira-Giacomelli, Á., Glaser, T., Arnaud-Sampaio, V. F., Andrejew, R., Dieckmann, L., Baranova, J., Lameu, C., Ratajczak, M. Z., & Ulrich, H. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-00965-3 · Cited by 145 · see citing works

The contribution of inflammatory astrocytes to BBB impairments in a brain-chip model of Parkinson’s disease

Jacquet, A. D. R., Alpaugh, M., Denis, H. L., Tancredi, J. L., Boutin, M., Decaestecker, J., Beauparlant, C., Herrmann, L., Saint-Pierre, M., Parent, M., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-39038-8 · Cited by 114 · see citing works

Behavioral Tests in Neurotoxin-Induced Animal Models of Parkinson’s Disease

Prasad, E. M., & Hung, S. (2020) · Antioxidants · doi:10.3390/antiox9101007 · Cited by 118 · see citing works

The Mechanisms by Which the Ketone Body D-β-Hydroxybutyrate May Improve the Multiple Cellular Pathologies of Parkinson's Disease

Norwitz, N. G., Hu, M. T., & Clarke, K. (2019) · Frontiers in Nutrition · doi:10.3389/fnut.2019.00063 · Cited by 110 · see citing works

The gut microbiome in Parkinson's disease: A culprit or a bystander?

Keshavarzian, A., Engen, P. A., Bonvegna, S., & Cilia, R. (2020) · Progress in brain research · doi:10.1016/bs.pbr.2020.01.004 · Cited by 104 · see citing works

Circulating cell-free mitochondrial DNA levels in Parkinson’s disease are influenced by treatment

Lowes, H., Pyle, A., Santibanez‐Koref, M., & Hudson, G. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00362-y · Cited by 92 · see citing works

A prebiotic diet modulates microglial states and motor deficits in α-synuclein overexpressing mice

Abdel-Haq, R., Schlachetzki, J. C., Boktor, J. C., Cantu-Jungles, T. M., Thron, T., Zhang, M., Bostick, J. W., Khazaei, T., Chilakala, S., Morais, L. H., et al. (2022) · eLife · doi:10.7554/elife.81453 · Cited by 82 · see citing works

Understanding the involvement of innate immunity and the Nrf2-NLRP3 axis on mitochondrial health in Parkinson's disease

Rajan, S., Tryphena, K. P., Khan, S. S., Vora, L. K., Srivastava, S., Singh, S. B., & Khatri, D. K. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101915 · Cited by 81 · see citing works

Parkinson's Disease: A Comprehensive Analysis of Fungi and Bacteria in Brain Tissue

Pisa, D., Alonso, R., & Carrasco, L. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.42257 · Cited by 80 · see citing works

An updated review on the versatile role of chrysin in neurological diseases: Chemistry, pharmacology, and drug delivery approaches

Talebi, M., Talebi, M., Farkhondeh, T., Kopustinskienė, D. M., Simal‐Gándara, J., Bernatonienė, J., & Samarghandian, S. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111906 · Cited by 80 · see citing works

Neuroinflammation: Mechanisms, Dual Roles, and Therapeutic Strategies in Neurological Disorders

García‐Domínguez, M. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47060417 · Cited by 85 · see citing works

The Interplay between α-Synuclein and Microglia in α-Synucleinopathies

Deyell, J., Sriparna, M., Ying, M., & Mao, X. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032477 · Cited by 71 · see citing works

The Therapeutic Prospects of Targeting IL-1R1 for the Modulation of Neuroinflammation in Central Nervous System Disorders

Luís, J. P., Simões, C. J. V., & Brito, R. M. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031731 · Cited by 69 · see citing works

Palmitoylethanolamide: A Nutritional Approach to Keep Neuroinflammation within Physiological Boundaries—A Systematic Review

Petrosino, S., & Moriello, A. S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249526 · Cited by 68 · see citing works

Role of ferroptosis pathways in neuroinflammation and neurological disorders: From pathogenesis to treatment

Mohan, S., Alhazmi, H. A., Hassani, R., Khuwaja, G., Maheshkumar, V. P., Aldahish, A. A., & Chidambaram, K. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e24786 · Cited by 67 · see citing works

Fractalkine (CX3CL1) signaling and neuroinflammation in Parkinson’s disease: Potential clinical and therapeutic implications

Angelopoulou, E., Paudel, Y. N., Shaikh, M. F., & Piperi, C. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104930 · Cited by 64 · see citing works

Are We What We Eat? Impact of Diet on the Gut–Brain Axis in Parkinson’s Disease

Alfonsetti, M., Castelli, V., & d’Angelo, M. (2022) · Nutrients · doi:10.3390/nu14020380 · Cited by 60 · see citing works

Empagliflozin repurposing in Parkinson’s disease; modulation of oxidative stress, neuroinflammation, AMPK/SIRT-1/PGC-1α, and wnt/β-catenin pathways

Mohammed, N. N., Tadros, M. G., & George, M. Y. (2023) · Inflammopharmacology · doi:10.1007/s10787-023-01384-w · Cited by 58 · see citing works

Reactive and Senescent Astroglial Phenotypes as Hallmarks of Brain Pathologies

Lazic, A., Balint, V., Ninković, D. S., Perić, M., & Stevanović, M. J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094995 · Cited by 58 · see citing works

Dual role of microglia in neuroinflammation and neurodegenerative diseases

Ajoolabady, A., Kim, B., Abdulkhaliq, A. A., Ren, J. T., Bahijri, S., Tuomilehto, J. O., Borai, A., Khan, J., & Praticò, D. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.107133 · Cited by 56 · see citing works

The Involvement of Neuroinflammation in the Onset and Progression of Parkinson’s Disease

Jurcău, A., Andronie-Cioară, F. L., Nistor-Cseppento, C. D., Pașcalău, N., Rus, M., Vasca, E., & Jurcău, M. C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914582 · Cited by 56 · see citing works

Neuroinflammation and Autophagy in Parkinson’s Disease—Novel Perspectives

Minchev, D. S., Kazakova, M., & Sarafian, V. S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314997 · Cited by 53 · see citing works

Does Gut Microbiota Influence the Course of Parkinson’s Disease? A 3-Year Prospective Exploratory Study in de novo Patients

Cilia, R., Piatti, M., Cereda, E., Bolliri, C., Caronni, S., Ferri, V., Cassani, E., Bonvegna, S., Ferrarese, C., Zecchinelli, A., et al. (2020) · Journal of Parkinson s Disease · doi:10.3233/jpd-202297 · Cited by 51 · see citing works

Mitochondrial Complex I as a Pathologic and Therapeutic Target for Parkinson’s Disease

Tryphena, K. P., Uppala, S. N., Pinjala, P., Srivastava, S., Singh, S. B., & Khatri, D. K. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00819 · Cited by 49 · see citing works

DAT and TH expression marks human Parkinson’s disease in peripheral immune cells

Gopinath, A., Mackie, P. M., Hashimi, B., Buchanan, A. M., Smith, A. R., Bouchard, R. S., Shaw, G., Badov, M., Saadatpour, L., Gittis, A. H., et al. (2022) · npj Parkinson s Disease · doi:10.1038/s41531-022-00333-8 · Cited by 45 · see citing works

Neutrophil to lymphocyte ratio in parkinson’s disease: a systematic review and meta-analysis

Hosseini, S., Shafiabadi, N., Khanzadeh, M., Ghaedi, A., Ghorbanzadeh, R., Azarhomayoun, A., Bazrgar, A., Pezeshki, J., Bazrafshan, H., & Khanzadeh, S. (2023) · BMC Neurology · doi:10.1186/s12883-023-03380-7 · Cited by 49 · see citing works

The complex role of inflammation and gliotransmitters in Parkinson's disease

Gopinath, A., Mackie, P. M., Phan, L. T., Tansey, M. G., & Khoshbouei, H. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105940 · Cited by 45 · see citing works

Novel Immunotherapeutic Approaches to Target Alpha-Synuclein and Related Neuroinflammation in Parkinson’s Disease

Zella, M. A. S., Metzdorf, J., Ostendorf, F., Maass, F., Muhlack, S., Gold, R., Haghikia, A., & Tönges, L. (2019) · Cells · doi:10.3390/cells8020105 · Cited by 43 · see citing works

Insights into the multifaceted role of circular RNAs: implications for Parkinson’s disease pathogenesis and diagnosis

Doxakis, E. (2022) · npj Parkinson s Disease · doi:10.1038/s41531-021-00265-9 · Cited by 43 · see citing works

Calmodulin binding proteins and neuroinflammation in multiple neurodegenerative diseases

O’Day, D. H., & Huber, R. J. (2022) · BMC Neuroscience · doi:10.1186/s12868-022-00695-y · Cited by 42 · see citing works

Intranasal glyphosate-based herbicide administration alters the redox balance and the cholinergic system in the mouse brain

Gallegos, C. E., Bartos, M., Gumilar, F., Raisman‐Vozari, R., Minetti, A., & Baier, C. J. (2020) · NeuroToxicology · doi:10.1016/j.neuro.2020.01.007 · Cited by 40 · see citing works

Monoamine signaling and neuroinflammation: mechanistic connections and implications for neuropsychiatric disorders

Saggu, S., Pless, A., Dew, E., Ware, D., Jiao, K., & Wang, Q. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1543730 · Cited by 42 · see citing works

Oral Administration of Silybin Protects Against MPTP-Induced Neurotoxicity by Reducing Pro-inflammatory Cytokines and Preserving BDNF Levels in Mice

Carreto, R. J. R., Zaldívar-Machorro, V. J., Pérez-Ramírez, D. J., Rodríguez-López, B. E., Meza, C., Garcı́a, E., Santamarı́a, A., & Chavarría, A. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03485-7 · Cited by 39 · see citing works

Co-treatment with natural HMGB1 inhibitor Glycyrrhizin exerts neuroprotection and reverses Parkinson’s disease like pathology in Zebrafish

Ren, Q., Jiang, X. J., Paudel, Y. N., Gao, X., Gao, D., Zhang, P., Sheng, W., Shang, X., Liu, K., Zhang, X., et al. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115234 · Cited by 38 · see citing works

Curcumin protects against rotenone-induced Parkinson's disease in mice by inhibiting microglial NLRP3 inflammasome activation and alleviating mitochondrial dysfunction

Xu, L., Hao, L.-P., Yu, J., Cheng, S.-Y., Fan, L., Ding, S.-M., & Zhang, R. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e16195 · Cited by 36 · see citing works

BV-2 Microglial Cells Respond to Rotenone Toxic Insult by Modifying Pregnenolone, 5α-Dihydroprogesterone and Pregnanolone Levels

Avallone, R., Lucchi, C., Puja, G., Codeluppi, A., Filaferro, M., Vitale, G., Rustichelli, C., & Biagini, G. (2020) · Cells · doi:10.3390/cells9092091 · Cited by 36 · see citing works

Neuroinflammation and histone H3 citrullination are increased in X-linked Dystonia Parkinsonism post-mortem prefrontal cortex

Petrozziello, T., Mills, A. N., Vaine, C. A., Penney, E. B., Fernandez‐Cerado, C., Legarda, G. P., Velasco-Andrada, M. S., Acuña, P. J., Ang, M. A. C., Muñoz, E. L., et al. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105032 · Cited by 35 · see citing works

Non-Coding RNAs in the Brain-Heart Axis: The Case of Parkinson’s Disease

Acharya, S., Salgado‐Somoza, A., Stefanizzi, F. M., Lumley, A. I., Zhang, L., Glaab, E., May, P., & Devaux, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186513 · Cited by 35 · see citing works

Impact of sex on neuroimmune contributions to Parkinson’s disease

Bourque, M., Morissette, M., Soulet, D., & Paolo, T. D. (2023) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2023.110668 · Cited by 34 · see citing works

Mechanistic evaluation of Ursolic acid against rotenone induced Parkinson’s disease– emphasizing the role of mitochondrial biogenesis

Peshattiwar, V., Muke, S., Kaikini, A. A., Bagle, S., Dighe, V. D., & Sathaye, S. S. (2020) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2020.03.003 · Cited by 34 · see citing works

Protective capacity of carotenoid trans-astaxanthin in rotenone-induced toxicity in Drosophila melanogaster

Akinade, T. C., Babatunde, O. O., Adedara, A. O., Adeyemi, O., Otenaike, T. A., Ashaolu, O. P., Johnson, T. O., Terriente-Félix, A., Whitworth, A. J., & Abolaji, A. O. (2022) · Scientific Reports · doi:10.1038/s41598-022-08409-4 · Cited by 34 · see citing works

Histaminergic System Activity in the Central Nervous System: The Role in Neurodevelopmental and Neurodegenerative Disorders

Szukiewicz, D. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25189859 · Cited by 32 · see citing works

Calpain mediated expansion of CD4+ cytotoxic T cells in rodent models of Parkinson's disease

Haque, A., Samantaray, S., Knaryan, V. H., Capone, M., Hossain, A., Matzelle, D. D., Chandran, R., Shields, D. C., Farrand, A. Q., Boger, H. A., et al. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113315 · Cited by 32 · see citing works

Neuroglial Senescence, α-Synucleinopathy, and the Therapeutic Potential of Senolytics in Parkinson’s Disease

Miller, S., Campbell, C. E., Jimenez-Corea, H. A., Wu, G., & Logan, R. A. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.824191 · Cited by 32 · see citing works

Advances in NURR1-Regulated Neuroinflammation Associated with Parkinson’s Disease

Al‐Nusaif, M., Lin, Y., Li, T., Cheng, C., & Le, W. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232416184 · Cited by 31 · see citing works

Activation and Regulation of NLRP3 by Sterile and Infectious Insults

Banerjee, S. K., Chatterjee, A., Gupta, S., & Nagar, A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.896353 · Cited by 31 · see citing works

Therapeutic potential of GDNF in neuroinflammation: Targeted delivery approaches for precision treatment in neurological diseases

Singh, G., Sikder, A., Phatale, V., Srivastava, S., Singh, S. B., & Khatri, D. K. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.104876 · Cited by 31 · see citing works

Soluble Epoxide Hydrolase Inhibition to Face Neuroinflammation in Parkinson’s Disease: A New Therapeutic Strategy

Pallàs, M., Vázquez, S., Sanfeliu, C., Galdeano, C., & Griñán‐Ferré, C. (2020) · Biomolecules · doi:10.3390/biom10050703 · Cited by 31 · see citing works

Intermittent fasting protects the nigral dopaminergic neurons from MPTP-mediated dopaminergic neuronal injury in mice

Ojha, U., Khanal, S., Park, P., Hong, J. T., & Choi, D. (2022) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2022.109212 · Cited by 30 · see citing works

Role of CD40(L)-TRAF signaling in inflammation and resolution—a double-edged sword

Strohm, L., Ubbens, H., Münzel, T. F., Daiber, A., & Daub, S. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.995061 · Cited by 29 · see citing works

New markers in Parkinson's disease

Bougea, A. M. (2020) · Advances in clinical chemistry · doi:10.1016/bs.acc.2019.12.001 · Cited by 28 · see citing works

Alpha-synuclein pathology, microgliosis, and parvalbumin neuron loss in the amygdala associated with enhanced fear in the Thy1-aSyn model of Parkinson's disease

Torres, E. R. S., Stanojlović, M., Zelikowsky, M., Bonsberger, J., Hean, S., Mulligan, C. K., Baldauf, L., Fleming, S. M., Masliah, E., Chesselet, M., et al. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105478 · Cited by 28 · see citing works

From Brain to Muscle: The Role of Muscle Tissue in Neurodegenerative Disorders

Duranti, E., & Villa, C. (2024) · Biology · doi:10.3390/biology13090719 · Cited by 29 · see citing works

Tissue and Stem Cell Sourced Extracellular Vesicle Communications with Microglia

Spellicy, S. E., & Stice, S. L. (2020) · Stem Cell Reviews and Reports · doi:10.1007/s12015-020-10011-y · Cited by 27 · see citing works

Long-Term Continuous Cervical Spinal Cord Stimulation Exerts Neuroprotective Effects in Experimental Parkinson’s Disease

Kuwahara, K., Sasaki, T., Yasuhara, T., Kameda, M., Okazaki, Y., Hosomoto, K., Kin, I., Okazaki, M., Yabuno, S., Kawauchi, S., et al. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00164 · Cited by 27 · see citing works

Brain Hepcidin Suppresses Major Pathologies in Experimental Parkinsonism

Liang, T., Qian, Z., Mu, M., Yung, W., & Ke, Y. (2020) · iScience · doi:10.1016/j.isci.2020.101284 · Cited by 26 · see citing works

Agathobaculum butyriciproducens Shows Neuroprotective Effects in a 6-OHDA-Induced Mouse Model of Parkinson’s Disease

Lee, D. W., Ryu, Y., Chang, D., Park, H., Go, J., Maeng, S.-Y., Hwang, D. Y., Kim, B., Lee, C., & Kim, K. (2022) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.2205.05032 · Cited by 25 · see citing works

Enhanced BDNF and TrkB Activation Enhance GABA Neurotransmission in Cerebellum in Hyperammonemia

Arenas, Y. M., Martinez‐García, M., Llansola, M., & Felipo, V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911770 · Cited by 26 · see citing works

3‐hydroxybutyrate in the brain: Biosynthesis, function, and disease therapy

Wang, B., Wu, J., Xiao, D., Wu, B., & Wei, D. (2023) · Brain‐X · doi:10.1002/brx2.6 · Cited by 26 · see citing works

Post-COVID-19 Parkinsonism and Parkinson’s Disease Pathogenesis: The Exosomal Cargo Hypothesis

Mysiris, D. S., Vavougios, G. D., Karamichali, E., Papoutsopoulou, S., Stavrou, V. T., Papayianni, E., Boutlas, S., Mavridis, T., Foka, P., Zarogiannis, S. G., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179739 · Cited by 25 · see citing works

Pro-Inflammatory Role of AQP4 in Mice Subjected to Intrastriatal Injections of the Parkinsonogenic Toxin MPP+

Prydz, A., Stahl, K., Zahl, S., Skauli, N., Skare, Ø., Ottersen, O. P., & Amiry-Moghaddam, M. R. (2020) · Cells · doi:10.3390/cells9112418 · Cited by 25 · see citing works

Inflammatory hallmarks in 6-OHDA- and LPS-induced Parkinson's disease in rats

OLİYNYK, Z., Rudyk, M. P., Dovbynchuk, T., Dziubenko, N., Tolstanova, G. M., & Skivka, L. M. (2023) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2023.100616 · Cited by 26 · see citing works

A New Generation of IMiDs as Treatments for Neuroinflammatory and Neurodegenerative Disorders

Kopp, K. O., Greer, M. E., Glotfelty, E. J., Hsueh, S., Tweedie, D., Kim, D. S., Reale, M., Vargesson, N., & Greig, N. H. (2023) · Biomolecules · doi:10.3390/biom13050747 · Cited by 24 · see citing works

Insights into dietary phytochemicals targeting Parkinson's disease key genes and pathways: A network pharmacology approach

Sasikumar, D. S. N., Thiruselvam, P., Sundararajan, V., Ravindran, R., Gunasekaran, S., Madathil, D., Kaliamurthi, S., Peslherbe, G. H., Selvaraj, G., & Sudhakaran, S. L. (2024) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2024.108195 · Cited by 24 · see citing works

Phosphodiesterase-4 Inhibition in Parkinson’s Disease: Molecular Insights and Therapeutic Potential

Roy, D., Balasubramanian, S., Krishnamurthy, P. T., Sola, P., & Rymbai, E. (2023) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-023-01349-1 · Cited by 24 · see citing works

Molecular mechanism of tumour necrosis factor alpha regulates hypocretin (orexin) expression, sleep and behaviour

Zhan, S., Che, P., Zhao, X., Li, N., Ding, Y., Liu, J., Li, S., Ding, K., Han, L. K., Huang, Z., et al. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14566 · Cited by 24 · see citing works

Unraveling neuroprotection in Parkinson’s disease: Nrf2–Keap1 pathway’s vital role amidst pathogenic pathways

Kaur, T., Sidana, P., Kaur, N., Choubey, V., & Kaasik, A. (2024) · Inflammopharmacology · doi:10.1007/s10787-024-01549-1 · Cited by 23 · see citing works

Ketotherapeutics for neurodegenerative diseases

Norwitz, N. G., Gilbert‐Jaramillo, J., Clarke, K., & Soto-Mota, A. (2020) · International review of neurobiology · doi:10.1016/bs.irn.2020.02.003 · Cited by 24 · see citing works

Neuroprotection by the Immunomodulatory Drug Pomalidomide in the Drosophila LRRK2WD40 Genetic Model of Parkinson’s Disease

Casu, M. A., Mocci, I., Isola, R., Pisanu, A., Boi, L., Mulas, G., Greig, N. H., Setzu, M. D., & Carta, A. R. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00031 · Cited by 22 · see citing works

The meningeal lymphatic vasculature in neuroinflammation

Olate‐Briones, A., Escalona, E., Salazar, C., Herrada, M. J., Liu, C., Herrada, A. A., & Escobedo, N. (2022) · The FASEB Journal · doi:10.1096/fj.202101574rr · Cited by 22 · see citing works

Parkinson’s Disease and the Metal–Microbiome–Gut–Brain Axis: A Systems Toxicology Approach

Forero-Rodríguez, L. J., Josephs‐Spaulding, J., Flor, S., Pinzón, A. M., & Kaleta, C. (2021) · Antioxidants · doi:10.3390/antiox11010071 · Cited by 22 · see citing works

Metabolic determinants of leukocyte pathogenicity in neurological diseases

Runtsch, M. C., Ferrara, G. B., & Angiari, S. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15169 · Cited by 20 · see citing works

Purinergic-associated immune responses in neurodegenerative diseases

Carracedo, S., Launay, A., Déchelle-Marquet, P.-A., Faivre, É., Blum, D. L., Delarasse, C., & Boué‐Grabot, É. (2024) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2024.102693 · Cited by 19 · see citing works

The interplay between neuroinflammatory pathways and Parkinson's disease

Ocak, P. E., Kocabıçak, E., Bekâr, A., & Temel, Y. (2023) · Experimental Neurology · doi:10.1016/j.expneurol.2023.114644 · Cited by 20 · see citing works

Neuro-modulatory impact of felodipine against experimentally-induced Parkinson's disease: Possible contribution of PINK1-Parkin mitophagy pathway

Abou-Hany, H. O., El‐Sherbiny, M., Elshaer, S. L., Said, E., & Moustafa, T. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.109909 · Cited by 19 · see citing works

Fenofibrate promotes neuroprotection in a model of rotenone-induced Parkinson’s disease

Barbiero, J. K., Ramos, D. C., Boschen, S. L., Bassani, T. B., Cunha, C. D., & Vital, M. A. B. F. (2022) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000699 · Cited by 18 · see citing works

Three-dimensional neuroimmune co-culture system for modeling Parkinson’s disease microenvironments in vitro

Rueda-Gensini, L., Serna, J. A., Rubio, D., Orozco, J. C., Bolaños, N. I., Cruz, J. C., & Muñoz-Camargo, C. (2023) · Biofabrication · doi:10.1088/1758-5090/ace21b · Cited by 19 · see citing works

Repurposing Pomalidomide as a Neuroprotective Drug: Efficacy in an Alpha-Synuclein-Based Model of Parkinson's Disease

Palmas, M. F., Ena, A., Burgaletto, C., Casu, M. A., Cantarella, G., Carboni, E., Etzi, M., Simone, A. D., Fusco, G., Cardia, M. C., et al. (2022) · Neurotherapeutics · doi:10.1007/s13311-022-01182-2 · Cited by 17 · see citing works

TREM2 in neurodegeneration and diseases

Abdulkhaliq, A. A., Alasiri, G., Kim, B., Khan, J., Ajoolabady, A., Yousof, S. M., Ren, J., Tuomilehto, J., Borai, A., Alrfaei, B. M., et al. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03505-7 · Cited by 16 · see citing works

Immunological Interfaces: The COVID-19 Pandemic and Depression

Perlmutter, A. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.657004 · Cited by 17 · see citing works

Role of toll-like receptor 4 and sex in 6-hydroxydopamine–induced behavioral impairments and neurodegeneration in mice

Somensi, N., Lopes, S. C., Gasparotto, J., Gonçalves, R. M., Ribeiro, C. T., Peixoto, D. O., Brum, P. O., Pinho, C. M., Agnes, J. P., Santos¹, L. F. D. S., et al. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.105215 · Cited by 16 · see citing works

Inulae Flos has Anti-Depressive Effects by Suppressing Neuroinflammation and Recovering Dysfunction of HPA-axis

Kim, J. S., Kim, J. H., Eo, H., Ju, I. G., Son, S.-R., Kim, J., Jang, D. S., & Oh, M. S. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04094-8 · Cited by 17 · see citing works

Mitophagy: A Bridge Linking HMGB1 and Parkinson’s Disease Using Adult Zebrafish as a Model Organism

Razali, K., Nasir, M. H. M., Kumar, J., & Mohamed, W. M. Y. (2023) · Brain Sciences · doi:10.3390/brainsci13071076 · Cited by 15 · see citing works

Assessment of CRISPRa-mediated gdnf overexpression in an In vitro Parkinson’s disease model

Guzmán-Sastoque, P., Sotelo, S., Esmeral, N. P., Albarracín, S. L., Sutachan, J. J., Reyes, L. H., Muñoz-Camargo, C., Cruz, J. C., & Bloch, N. I. (2024) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2024.1420183 · Cited by 15 · see citing works

Immune System and Neuroinflammation in Idiopathic Parkinson’s Disease: Association Analysis of Genetic Variants and miRNAs Interactions

Strafella, C., Caputo, V., Termine, A., Assogna, F., Pellicano, C., Pontieri, F. E., Macchiusi, L., Minozzi, G., Gambardella, S., Centonze, D., et al. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.651971 · Cited by 14 · see citing works

Coriandrum sativum attenuates microglia mediated neuroinflammation and MPTP-induced behavioral and oxidative changes in Parkinson’s disease mouse model

Koppula, S., Alluri, R., & Kopalli, S. R. (2021) · EXCLI journal · doi:10.17179/excli2021-3668 · Cited by 15 · see citing works

DRD2 activation inhibits choroidal neovascularization in patients with Parkinson’s disease and age-related macular degeneration

Mathis, T., Baudin, F., Mariet, A., Augustin, S., Bricout, M., Przegralek, L., Roubeix, C., Benzenine, É., Blot, G., Nous, C., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci174199 · Cited by 14 · see citing works

Decoding natural products for neuroprotection: Pathway networks and structural insights for drug development

Ghosh, S., Debnath, I., Bhunia, S., Nandi, S., Ashique, S., Nayak, A., Mallick, S., & Basak, S. (2025) · Chinese Herbal Medicines · doi:10.1016/j.chmed.2025.09.005 · Cited by 15 · see citing works

The c-Abl/p73 pathway induces neurodegeneration in a Parkinson's disease model

Marín, T., Valls, C., Jerez, C., Huerta, T., Elgueta, D., Vidal, R. L., Alvarez, A. R., & Cancino, G. I. (2022) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2022.10.006 · Cited by 14 · see citing works

Do Bacterial Outer Membrane Vesicles Contribute to Chronic Inflammation in Parkinson’s Disease?

Koukoulis, T. F., Beauchamp, L. C., Kaparakis‐Liaskos, M., McQuade, R. M., Purnianto, A., Finkelstein, D. I., Barnham, K. J., & Vella, L. J. (2024) · Journal of Parkinson s Disease · doi:10.3233/jpd-230315 · Cited by 14 · see citing works

Neuroprotectant Activity of Novel Water-Soluble Synthetic Neurosteroids on Organophosphate Intoxication and Status Epilepticus-Induced Long-Term Neurological Dysfunction, Neurodegeneration, and Neuroinflammation

Reddy, D. S., Singh, T., Ramakrishnan, S., Huber, M., & Wu, X. Y. (2023) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.123.001819 · Cited by 14 · see citing works

Repetitive transcranial magnetic stimulation alleviates glial activation through suppressing HMGB1/TLR4 pathway in a rat model of Parkinson’s disease

Han, C., Zhang, X., Dou, K., Yao, W., Yao, M.-Y., Wan, Q., & Xie, A. (2023) · Molecular Biology Reports · doi:10.1007/s11033-023-08561-8 · Cited by 13 · see citing works

Noninvasive Neuromodulation in Parkinson’s Disease: Insights from Animal Models

Muksuris, K., Scarisbrick, D. M., Mahoney, J. J., & Cherkasova, M. V. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12175448 · Cited by 13 · see citing works

Neuroinflammation and Parkinson’s Disease—From Neurodegeneration to Therapeutic Opportunities

Araújo, B., Caridade-Silva, R., Soares-Guedes, C., Martins‐Macedo, J., Gomes, E. D., Monteiro, S., & Teixeira, F. G. (2022) · Cells · doi:10.3390/cells11182908 · Cited by 198 · see citing works

Microglia, Astrocytes, and Oligodendrocytes in Parkinson’s Disease: Neuroinflammatory Crosstalk and Emerging Therapeutic Strategies

Kędzia, D., Galita, G., Majsterek, I., & Rozpędek‐Kamińska, W. (2026) · Biomolecules · doi:10.3390/biom16010156 · Cited by 11 · see citing works

Neuroinflammation, oxidative stress, and the pathogenesis of Parkinson’s disease

Mosley, R. L., Benner, E. J., Kadiu, I., Thomas, M., Boska, M. D., Hasan, K. M., Laurie, C. D., & Gendelman, H. E. (2006) · Clinical Neuroscience Research · doi:10.1016/j.cnr.2006.09.006 · Cited by 388 · see citing works

Significant roles of neuroinflammation in Parkinson’s disease: therapeutic targets for PD prevention

Lee, Y., Lee, S., Chang, S., & Lee, J. (2019) · Archives of Pharmacal Research · doi:10.1007/s12272-019-01133-0 · Cited by 169 · see citing works

Neurodegeneration and Inflammation—An Interesting Interplay in Parkinson’s Disease

Marogianni, C., Sokratous, M., Dardiotis, E., Hadjigeorgiou, G. M., Bogdanos, D. P., & Xiromerisiou, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228421 · Cited by 369 · see citing works